Target intelligence / Profile preview

Steroid 5-alpha-reductase type 1 (5αR1)

Target
5αR1
Molecular classification
Enzyme, Steroid reductase
01

Overview

Steroid 5-alpha-reductase type 1 (5αR1) is an enzyme encoded by the SRD5A1 gene that catalyzes the conversion of testosterone to dihydrotestosterone (DHT), as well as similar reductions for other steroid hormones. It is predominantly expressed in the liver and skin. It is a therapeutic target for benign prostatic hyperplasia and is implicated in various metabolic diseases and cancer.

Other names
5-alpha-reductase 1SRD5A13-oxo-5-alpha-steroid 4-dehydrogenase 1
02

Mechanism of action

Inhibition of 5-alpha-reductase activity, reducing DHT production.

03

Biological functions

Steroid metabolismAndrogen biosynthesisNeurosteroid synthesis
04

Disease associations

Endometrioid endometrial adenocarcinomaInsulin resistanceHepatic steatosisHepatic fibrosis
05

Safety considerations

Potential metabolic side effects (insulin resistance, hepatic steatosis)Individual variability in response to inhibitors
06

Interacting drugs

Dutasteride

1 more in the full profile.

07

Biomarkers

Intratumoral DHT concentrationsSRD5A1 expression levels

Beyond the preview

Go deeper on Steroid 5-alpha-reductase type 1 (5αR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Steroid 5-alpha-reductase type 1 (5αR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call